Medical News on Cancer
For Patients With Resected SCLC Or Large-Cell Neuroendocrine Carcinoma, Chemotherapy Found To Be Effective
Jun 18, 2012
Research presented in the July 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concluded that patients with limited large cell neuroendocrine tumors or with limited stage small-cell lung cancer who were treated with perioperative chemotherapy and surgery had better overall survival outcomes than patients treated with surgery alone... Read More
Stereotactic Ablative Radiotherapy Effective Treatment For Non-Small Cell Lung Cancer
Jun 18, 2012
Until recently, many elderly patients with stage I non-small cell lung cancer were left untreated because treatment may not improve their quality of life. However, stereotactic ablative radiotherapy (SABR) has become one of the standards of treatment for these patients. The outpatient treatment given over a two-week period allows frail patients to undergo the treatment... Read More
Hope That Virtual Colonoscopy Without Laxative Will Increase Colon Exams And Decrease Colorectal Cancer Rates
Jun 18, 2012
Computed tomographic colonography (CTC), also known as virtual colonoscopy, administered without laxatives is as accurate as conventional colonoscopy in detecting clinically significant, potentially cancerous polyps, according to a study performed jointly at the San Francisco VA Medical Center, the University of California, San Francisco and Massachusetts General Hospital... Read More
Virus Kills Cancer By Hitching Ride On Blood Cells
Jun 17, 2012
Scientists have discovered when a cancer-killing virus is injected in the bloodstream it hitches a ride on blood cells and evades attack from the immune system, allowing it to reach cancer tumors, and start destroying cancer cells... Read More
Growing, Aging Population And Increased Survival Prompt Estimate Of Nearly 18 Million Cancer Survivors In The US By 2022
Jun 16, 2012
The number of Americans with a history of cancer, currently estimated to be 13.7 million, will grow to almost 18 million by 2022, according to a first-ever report by the American Cancer Society in collaboration with the National Cancer Institute (NCI)... Read More
Successful With New Immune Approach To Fighting Some Cancers
Jun 15, 2012
A national research collaboration of senior researchers, including a researcher from Moffitt Cancer Center, has found that 20 to 25 percent of "heavily pre-treated" patients with a variety of cancers who enrolled in a clinical trial had "objective and durable" responses to a treatment with BMS-936558, an antibody that specifically blocks programmed cell death 1 (PD-1)... Read More
Single Drugs That 'Target' Tumor Cells Unlikely, In The Long Term, To Benefit Patients With Advanced Cancers
Jun 15, 2012
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns... Read More
New Skin Cancer Drug Hailed As 'Greatest Advance Yet' By New England Journal Of Medicine
Jun 15, 2012
Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine... Read More
What Is HPV (Human Papilloma Virus)?
Jun 15, 2012
HPV, or Human Papilloma Virus, is a virus from the papillomavirus family that affects human skin and the moist membranes that line the body, such as the throat, mouth, feet, fingers, nails, anus and cervix. There are over 100 types, of which 40 can affect the genital area. Most known HPV types cause no symptoms to humans... Read More
Cervical Cancer Cellular Origin Discovered, Major Breakthrough
Jun 14, 2012
Researchers have identified a set of cells in the cervix that are responsible for human papillomaviruses (HPV) related cervical cancers, according to a study published in the Proceedings of the National Academy of Sciences (PNAS)... Read More
Previous Page Next Page